Dr Michael Rosenblatt has over four decades of leadership experience across biopharmaceutical companies and academic institutions, and as a practicing physician. He has served as a founding scientist, scientific advisory board member, and director of more than a dozen biopharmaceutical companies.
US-based Dr Rosenblatt is a senior partner of Flagship Pioneering, a leading-edge innovation organisation that conceives, creates and develops first-in-category life science companies. He helped launch several renowned biotechnology companies in the Flagship ecosystem, including providing counsel on clinical development strategies and chairing or serving on their scientific or clinical advisory committees.
Dr Rosenblatt was the executive vice president and chief medical officer of Merck, one of the world’s leading global biopharmaceutical companies, from 2009 to 2016. He was also the Dean of Tufts University School of Medicine.
He received his BA summa cum laude from Columbia University; his MD magna cum laude from Harvard Medical School; and completed his internship, residency and endocrinology training at Massachusetts General Hospital.
